Apollo Medical Holdings Inc
AMEH
Get informed when a big investor buys or sells
+ FollowCurrent Fair Value
122.4% upsideUndervalued by 122.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.83 Billion |
|---|---|
| Enterprise Value | $1.44 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.44 |
| Beta | 1.04 |
| Outstanding Shares | 48,853,678 |
Return
| Return on Equity | 3.87% |
|---|---|
| Return on Assets | 1.31% |
| Return on Invested Capital | -2.92% |
Valuation & Multiples
| P/E Ratio | 60.79 |
|---|---|
| PEG | 52.54 |
| Price to Sales | 0.57 |
| Price to Book Ratio | 3.71 |
| Enterprise Value to Revenue | 0.41 |
| Enterprise Value to EBIT | -30.58 |
| Enterprise Value to Net Income | 46 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1591▼ 232.34% |
|---|---|
| Total Calls | 256,500▲ 2150.00% |
| Total Puts | 40,800▲ 44.17% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 60.76%▼ 0.56% |
|---|---|
| Total Invested | $733.42M▲ 1.25% |
| Investors Holding | 175▼ 2.00% |
ESG Score
No data
About Apollo Medical Holdings Inc
ApolloMed is a leading physician-centric, technology-enabled healthcare management company. Leveraging its proprietary population health management and healthcare delivery platform, ApolloMed operates an integrated, value-based healthcar...
Relevant Senate Committees
Has primary jurisdiction over Medicare and Medicaid, which are critical funding sources and patient populations for ApolloMed's value-based healthcare model, along with overall tax policy impacting corporate profitability.
Determines discretionary federal spending, including funding for health programs (Medicare, Medicaid, NIH, VA), which directly impacts the revenue streams and operational environment for ApolloMed and its network.
Direct oversight of healthcare policy, FDA regulations (potentially for their technology platform), and labor laws impacting healthcare providers are central to ApolloMed's operations and strategy.
Focuses on issues affecting older Americans, a key demographic for value-based care and population health management (e.g., Medicare Advantage). Hearings on drug pricing and care quality directly impact ApolloMed's cost management and service delivery.
Jurisdiction over interstate commerce, data privacy (critical in healthcare), and technology regulation directly impacts ApolloMed's 'technology-enabled' platform and patient data management practices.